Evidence Synthesis
Here is a standard_shift narrative based on the provided payload: INDOAMIN's gross margin accelerated to 34.39%, up from 12.41%.
Loading stock analysis…
Loading stock analysis…
Evidence Synthesis
Last synthesized: 5 Sept 2026, 03:03
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence Synthesis
Here is a standard_shift narrative based on the provided payload: INDOAMIN's gross margin accelerated to 34.39%, up from 12.41%.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 34.39 % | 12.41 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 12.41 % | 6.52 | ▲ |
| REVENUE_GROWTH_YOY | 30.3 % | 6.1 | ▲ |
| PRICE_CHANGE_PERCENT | 1.352 % | — | - |
| DAILY_VOLUME | 50,224 shares | 89,388 | ▼ |
| CLOSE_PRICE | 125.96 INR | 124.28 | ▲ |